CO5070581A1 - VACCINES - Google Patents
VACCINESInfo
- Publication number
- CO5070581A1 CO5070581A1 CO99020598A CO99020598A CO5070581A1 CO 5070581 A1 CO5070581 A1 CO 5070581A1 CO 99020598 A CO99020598 A CO 99020598A CO 99020598 A CO99020598 A CO 99020598A CO 5070581 A1 CO5070581 A1 CO 5070581A1
- Authority
- CO
- Colombia
- Prior art keywords
- ester
- composition
- polyoxyethylene ether
- vesicle
- antigen
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Una composición de vacuna que comprende un éter de polioxietileno o un éster de polioxietileno, en combinación con un excipiente farmacéuticamente aceptable, y un antígeno o composición antigénica, en la que el éter o éster de polioxietileno no está en la forma de una vesícula. Una composición de vacuna, que comprende un tensioactivo de fórmula (I): HO (CH2CH2O)n-A-Ren la que n es 1-50, A es un enlace o -C(O) -, R es alquil de C1-50 o fenil-alquilo de C1-50; un excipiente farmacéuticamente aceptable y un antígeno o composición antigénica, en la que el tensioactivo no está en la forma de una vesícula. 1Uso de un éter o éster de polioxietileno en la elaboración de una composición adyuvante, en el que el éter o éster de polioxietileno está presente en la composición adyuvante en una forma no vesicular. <EMI FILE="99020598_1" ID="1" IMF=JPEG >A vaccine composition comprising a polyoxyethylene ether or a polyoxyethylene ester, in combination with a pharmaceutically acceptable excipient, and an antigen or antigenic composition, in which the polyoxyethylene ether or ester is not in the form of a vesicle. A vaccine composition, comprising a surfactant of formula (I): HO (CH2CH2O) nA-Ren which n is 1-50, A is a bond or -C (O) -, R is C1-50 alkyl or C1-50 phenyl-alkyl; a pharmaceutically acceptable excipient and an antigen or antigenic composition, in which the surfactant is not in the form of a vesicle. 1 Use of a polyoxyethylene ether or ester in the preparation of an adjuvant composition, in which the polyoxyethylene ether or ester is present in the adjuvant composition in a non-vesicular form. <EMI FILE = "99020598_1" ID = "1" MFI = JPEG>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9807805.8A GB9807805D0 (en) | 1998-04-09 | 1998-04-09 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5070581A1 true CO5070581A1 (en) | 2001-08-28 |
Family
ID=10830239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99020598A CO5070581A1 (en) | 1998-04-09 | 1999-04-08 | VACCINES |
Country Status (3)
Country | Link |
---|---|
CO (1) | CO5070581A1 (en) |
GB (1) | GB9807805D0 (en) |
ZA (1) | ZA200004975B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2173376T3 (en) | 2007-08-02 | 2015-08-31 | Biondvax Pharmaceuticals Ltd | Multimeric multiepitope influenza vaccines |
-
1998
- 1998-04-09 GB GBGB9807805.8A patent/GB9807805D0/en not_active Ceased
-
1999
- 1999-04-08 CO CO99020598A patent/CO5070581A1/en unknown
-
2000
- 2000-09-18 ZA ZA200004975A patent/ZA200004975B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB9807805D0 (en) | 1998-06-10 |
ZA200004975B (en) | 2001-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2132547A1 (en) | Vaccines Containing Non-Ionic Surfactant Vesicles | |
IS4518A (en) | New vaccine formulation | |
AR025749A1 (en) | VACCINES | |
ES2118963T3 (en) | COMBINED VACCINES, CONTAINING HEPATITIS B SURFACE ANTIGEN AND OTHER ANTIGENS. | |
ATE219686T1 (en) | PROTEIN-TYPE ADJUVANTS | |
ATE196737T1 (en) | ADJUVANTS FOR VACCINES AGAINST RESPIRATORY SYNCITIAL VIRUS | |
NO970993L (en) | Mutant enterotoxin which is effective as a non-toxic oral adjuvant | |
ATE272410T1 (en) | ADJUVANT COMPOSITIONS FOR INCREASE THE IMMUNE RESPONSE TO POLYNUCLEOTIDE-BASED VACCINES | |
EP1618889A3 (en) | Influenza Vaccine | |
IL144671A0 (en) | Immunological adjuvants compounds compositions and methods of use thereof | |
ATE280585T1 (en) | VACCINES CONTAINING PAUCILAMELLAR LIPID VESICLES AS ADJUVANTS | |
DE69131709T2 (en) | Vaccine Compositions Containing Liposomes | |
MXPA04002490A (en) | Interleukin-12 as a veterinary vaccine adjuvant. | |
GEP20053446B (en) | Adjuvant Combination Formulations | |
CO5070581A1 (en) | VACCINES | |
WO2001070265A3 (en) | Lipopeptide adjuvants | |
DE60031243D1 (en) | VACCINATION OF VACCINES AGAINST TUBERCULOSIS WITH MONOGLYCERIDES OR FATTY ACIDS AS ADJUVANT | |
WO2002038176A3 (en) | Immunogenic compositions comprising liver stage malarial antigens | |
CO5280199A1 (en) | COMPOSITION | |
EP2116257A3 (en) | Parenteral vaccine formulations and uses thereof | |
ATE175120T1 (en) | ATTENUATED BACKMUTATED VIRUS VACCINE AGAINST MAREK'S DISEASE SEROTYPE-1 | |
WO2002072622A3 (en) | Vaccine antigens against infection by chlamydia trachomatis | |
MX9710523A (en) | Vaccines against hepatitis c. |